PV Bulletin
PvBulletin

Category

Country Guides

Country GuidesHealth CanadaCanada

Health Canada updates RMP submission guidance effective 1 July 2025

Relevant for
Local Safety OfficerSignal Management LeadLabeling LeadRegulatory Intelligence Lead+3 more
Action needed

1) Retrieve and review the updated “Submitting risk management plans guidance document” (PDF) and linked templates referenced from the overview (e.g., RMP note to reviewer, Canadian-specific addendum, RMP summary template) and map deltas vs the superseded 2015 approach. 2) Update Canada submission checklists/work instructions for the 1 July 2025 effective date, including the requirement that the RMP include a summary in English and French and use of the RMP summary attestation/acknowledgment form. 3) Ask Regulatory Intelligence/RA to brief PV leadership on the Agile Licensing notice timeline (RMP provisions in force 1 April 2027) and confirm how transitional provisions will be operationalized for existing RMPs submitted prior to that date.

Process impact
Label GovernanceRisk ManagementLocal Affiliate Compliance
SOP impact

5 SOPs may need review

Urgency: HighConfidence: high
Read impact brief
Country GuidesMhraUnited Kingdom

MHRA clarifies PSUR submission routes for Category 1 vs Category 2

Relevant for
Local Safety OfficerSignal Management LeadRegulatory Intelligence LeadPV Operations Lead+3 more
Action needed

1) Map portfolio to MHRA’s Category 1 vs Category 2/NI MA status referenced in the Windsor Framework PV guidance; 2) Update PSUR submission SOPs/work-instructions and submission trackers to ensure Category 1 PSURs route via the MHRA PSUR portal and Category 2/NI MA PSURs route via the EU PSUR Repository (and confirm when no separate MHRA submission is needed); 3) Re-check related MHRA PV procedure guidance for any additional submission/documentation expectations impacting signals, RMPs and PASS.

Process impact
Signal ValidationLocal Affiliate ComplianceInspection Readiness
SOP impact

8 SOPs may need review

Urgency: HighConfidence: high
Read impact brief
Country GuidesMhraUnited Kingdom

MHRA hub consolidates GB medical device PMS, MORE reporting and PSUR

Relevant for
Local Safety OfficerRegulatory Intelligence LeadPV Operations LeadMedical Device Vigilance Lead+3 more
Action needed

Safety/Device Vigilance owner to: (1) confirm SOPs and training link to MHRA’s “Medical devices: post-market surveillance” collection as the live index; (2) validate operational readiness to submit adverse incident and FSCA-related reports via MHRA’s referenced MORE route; (3) confirm device PSUR process uses MHRA-linked standardised PSUR format and PSUR guidance tied to the Regulations 2024 framework; (4) update internal regulatory intelligence trackers with the 16 June 2025 in-force date cited across MHRA guidance, and monitor related MHRA future regime pages for further updates.

Process impact
Local Affiliate ComplianceDevice VigilanceInspection Readiness
SOP impact

6 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
Country GuidesHealth Canada

Health Canada Q&A accepts PSUR or PBRER for C.01.018 reports

Relevant for
Local Safety OfficerSignal Management LeadPV Quality LeadPV Technology / CSV Lead+2 more
Action needed

Health Canada update requires triage for Local Affiliate Compliance, Inspection Readiness, Risk Management; confirm local obligations and document follow-up actions.

Process impact
Local Affiliate ComplianceInspection ReadinessRisk Management
SOP impact

5 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief
Country GuidesMhra

UK MHRA refreshes PV procedures and adds decentralised manufacture UK GVP

Relevant for
Local Safety OfficerSignal Management LeadRegulatory Intelligence LeadPV Operations Lead+4 more
Action needed

Mhra update requires triage for Signal Validation, Risk Management, Local Affiliate Compliance; confirm local obligations and document follow-up actions.

Process impact
Signal ValidationRisk ManagementLocal Affiliate Compliance
SOP impact

9 SOPs may need review

Urgency: HighConfidence: medium
Read impact brief

Get updates for your PV role

Subscribe to receive impact-first pharmacovigilance updates tailored by role and workflow.

Current context: role All, workflow All.